The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Final results: A phase I study of sorafenib and palliative radiation in patients with malignancy in the thorax, abdomen, or pelvis.
A. M. Brade
Research Funding - Bayer
S. W. Kim
No relevant relationships to disclose
C. Chung
No relevant relationships to disclose
J. F. Wan
No relevant relationships to disclose
B. Southwood
No relevant relationships to disclose
N. Chaudary
No relevant relationships to disclose
L. Wang
No relevant relationships to disclose
M. Milosevic
Research Funding - Bayer
A. M. Oza
Research Funding - Bayer